Background Few diagnostic and prognostic biomarkers are available for head-and-neck
squamous cell carcinoma (HNSCC). Long non-coding RNAs (lncRNAs) have shown …

Head and neck squamous cell carcinoma (HNSCC) is an aggressive epithelial malignancy
characterized by frequent mutations and metastasis. Long noncoding RNAs (lncRNAs) have …

Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer. Early detection
and management of HNSCC may prevent progression of the disease. Long non‑coding …

Head and neck squamous cell carcinoma (HNSCC) is a prevalent and prognostically
challenging cancer worldwide. The role of long non-coding RNAs (lncRNAs) in cancer …

Objective: In this study, we aimed to expand current knowledge of head and neck squamous
cell carcinoma (HNSCC)-associated long noncoding RNAs (lncRNAs), and to discover …

Multiple studies have shown that long non-coding RNAs (lncRNAs) play an important role in
the occurrence and development of diverse cancers. Cancer susceptibility candidate 19 …

Abstract Lnc RNA Cancer Susceptibility Candidate 2 (CASC2) has been shown to be
aberrantly expressed in multiple types of cancer and might serve as a prognosis biomarker …

Deregulated long noncoding RNAs (lncRNA) have been critically implicated in
tumorigenesis and serve as novel diagnostic and prognostic biomarkers. Here we sought to …

Background: Long non-coding RNAs (LncRNAs), with the length of over 200 nucleotides,
that originate from intergenic, antisense, or promoter-proximal regions, are a large family of …

Emerging evidence has demonstrated that long noncoding RNAs (lncRNAs) play vital roles
in tumorigenesis and progression. LncRNAs can participate in various biological processes …